Cargando…

Drug Repositioning of the α(1)-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?

Failure of conventional treatments is often observed in cancer management and this requires the development of alternative therapeutic strategies. However, new drug development is known to be a high-failure process because of the possibility of a lower efficacy than expected for the drug or appearan...

Descripción completa

Detalles Bibliográficos
Autores principales: Florent, Romane, Poulain, Laurent, N’Diaye, Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432507/
https://www.ncbi.nlm.nih.gov/pubmed/32727149
http://dx.doi.org/10.3390/ijms21155339

Ejemplares similares